Arch Therapeutics Inc ARTHQ
$0.00
Last Updated: Dec 30, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ARTHQ Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Arch Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Arch Therapeutics Inc. Stock Analysis ARTHQ
United States Health Care Nano Cap Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.
Arch Therapeutics Inc (ARTHQ) Chart
Financial Metrics & Statements of Arch Therapeutics Inc (ARTHQ)
FAQ's for Arch Therapeutics Inc (ARTHQ)
- As of August 2026, Arch Therapeutics Inc ARTHQ is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Arch Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Arch Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Arch Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Arch Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Arch Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Arch Therapeutics Inc (ARTHQ)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
